Mit Canada
 
 
MIT CANADA specializes in the development, manufacturing and marketing of needle free jet injectors for veterinary and human applications.

medical international technology products
Click here
 

Medical International Technology Inc. Files SEC form 10-K/A, Annual Report
Tuesday, November 24th 2009

Annual Report


Item 6. Management's Discussion and Analysis or Plan of Operations

When used in this Form 10-KSB and in future filings by the company with the Commission, statements identified by the words "believe", "positioned", "estimate", "project", "target", "continue", "will", "intend", "expect", "future", "anticipates", and similar expressions express management's present belief, expectations or intentions regarding the company's future performance within the meaning of the Private Securities Litigation Reform Act of 1995. The safe harbor in the Private Securities Litigation Act of 1995 does not apply to statements made in this document. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The company has no obligations to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

Overview

The following discussions and analysis should be read in conjunction with the Company's consolidated financial statements and the notes presented following the financial statements. The discussion of results, causes and trends should not be construed to imply any conclusion that such results or trends will necessarily continue in the future.

Medical International Technology, Inc. (MIT) is receiving revenues from sales. The company has maintained operations from these revenues and through equity and debt financing. The company has been dependent on advances from related parties to maintain operations. There are no agreements, assurances or commitments to continue providing these advances. Products are currently developed, assembled and shipped from our facility. Component manufacturing is subcontracted to various suppliers and machine shops.

Distribution agreements are being sought worldwide for the Company's products.

Critical Accounting Policies

The accompanying discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosure of contingent assets and liabilities. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We base our estimates and judgments on historical experience and all available information. However, future events are subject to change, and the best estimates and judgments routinely require adjustment. US GAAP requires us to make estimates and judgments in several areas, including those related to recording various accruals, income taxes, the useful lives of long-lived assets, such as property and equipment and intangible assets, and potential losses from contingencies and litigation. We believe the policies discussed below are the most critical to our financial statements because they are affected significantly by management's judgments, assumptions and estimates.

 

 

flecheMedical International Technology Inc. Financials

flecheForm 10-Q for Medical International Technology Inc.

flecheMajor research report on MDLH just released by Grass Roots Research and Distribution, Inc.

flecheMIT China joint venture is preparing a major commercial launch in July 2010

flecheMajor milestone achieved by our joint venture in China

flecheDr. Francis Bellido named Vice-President and Chief Strategy Officer of Medical International Technology Inc.

flecheStock Alert for Medical International Technology Inc. Issued by StockPreacher

flecheMedical International Technology (MIT) Inc. targeting a multi-billion dollar market with 3 new products

flecheMedical International Technology Inc. Financials

flecheMedical International Technology Inc. - Corporate Update

flecheMr. Harold Gervais nominated to MIT's Advisory Board and appointed as Vice-President and Chief Financial Officer

Medical International Technology Inc.is pleased to announce the nomination of...

Medical International Technology Inc.is pleased to announce...

Medical International Technology Inc.Financials

Medical International Technology Inc.is pleased to announce that it has received clearance by FINRA...

Medical International Technology Inc.Financials

Medical International Technology Inc. Files SEC form 10-K, Annual Report

Medical International Technology Inc.Financials

Medical International Technology Inc. Files SEC form 10-Q/A, Quarterly Report

Medical International Technology Inc. Files SEC form 10-K/A, Annual Report

Medical International Technology Inc. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Revie

Medical International Technology Inc. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sal

 
fleche All the new releases